Visceral adipose tissue and risk of nonalcoholic fatty liver disease: A Mendelian randomization study
Clinical Endocrinology · 2023-10 · 99 (4) · 370-377
DOI: 10.1111/cen.14953 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Endocrinology, online erschienen am 10.08.2023. Verfasst von Min Tao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Genome-Wide Association Study, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
Objective
Observational studies have shown that visceral adipose tissue (VAT) can increase the risk of nonalcoholic fatty liver disease (NAFLD). However, the causality of this association remains unclear. Therefore, this study aimed to explore the causal association between VAT and NAFLD.
Design
We obtained single‐nucleotide polymorphisms strongly associated with VAT ( n = 325,153) from large‐scale genome‐wide association studies. Summary‐level data for NAFLD (2275 cases and 375,002 controls) was available from the FinnGen consortium. We applied two‐sample Mendelian randomization (MR) to determine the causal association between VAT and NAFLD. The random‐effects inverse‐variance weighted (IVW) method was used as the main MR approach, with alternate methods including the weighted median (WM) approach and MR‐Egger regression. In addition, we conducted sensitivity analyses to assess the robustness of MR analyses.
Results
Genetically predicted higher VAT mass is causally associated with a higher risk of NAFLD. The three analysis results of MR were as follows: IVW ( β = 0.665, odds ratio [OR] = 1.944, 95% confidence interval [CI] = 1.482–2.550, p = 1.58e−06], WM ( β = 0.615, OR = 1.849, 95% CI = 1.272–2.689, p = 1.29e−03), and MR‐Egger ( β = 1.250, OR = 3.490, 95% CI = 1.522–7.998, p = 3.52e−03). In the sensitivity analysis, the data showed heterogeneity ( p < 0.05) but no pleiotropy ( p = 0.145).
Conclusion
This study provided genetic evidence that higher VAT mass causally associated with a higher risk of NAFLD. The amount of VAT could be reduced using a therapeutic strategy for managing NAFLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
ORCID-Profile: Min Tao, Lili Zhang
Zitieren
APA
Tao, M., Zhou, G., Liu, J., He, M., Wang, C., Luo, X., & Zhang, L. (2023). Visceral adipose tissue and risk of nonalcoholic fatty liver disease: A Mendelian randomization study. Clinical Endocrinology, 99(4), 370-377. https://doi.org/10.1111/cen.14953
Vancouver
Tao M, Zhou G, Liu J, He M, Wang C, Luo X, et al. Visceral adipose tissue and risk of nonalcoholic fatty liver disease: A Mendelian randomization study. Clinical Endocrinology. 2023;99(4):370-377. doi:10.1111/cen.14953
BibTeX
@article{Tao2023,
author = {Tao, Min and Zhou, Guanghong and Liu, Jing and He, Miao and Wang, Cong and Luo, Xie and Zhang, Lili},
title = {Visceral adipose tissue and risk of nonalcoholic fatty liver disease: A Mendelian randomization study},
journal = {Clinical Endocrinology},
year = {2023},
volume = {99},
number = {4},
pages = {370--377},
doi = {10.1111/cen.14953}
}
EUVIMED